ARR
€1.15m
+6.8% MoM · +228.6% since Nov 25
Software around the instruments, not another model of the protein.
1.60x
ARR
€1.15m
+6.8% MoM · +228.6% since Nov 25
Net burn
€240k / mo
Implied cash €5.04m
Runway
21 mo
Outside the nine-month line
People
14
NRR 127% · GM 71%
info
Sable is in the pipeline as a lab copilot. Cinder already sits with three of the same Oxford groups. This is a conflict of attention, not a legal conflict.
Suggested action. Tomasz should walk Elena through the account list before Thursday’s Sable meeting. If the buyers are the same, we do not need both.
€m, monthly
€m per month
Monitoring note
Cinder is early and behaving like an early company should: small team, high retention, long runway, no invented ARR story. Leave it alone operationally. The only action is to stop the pipeline from creating a second bet on the same bench.